Follow
Michael S. Regan
Michael S. Regan
Brigham and Women's Hospital
Verified email at bwh.harvard.edu
Title
Cited by
Cited by
Year
Blood–brain-barrier organoids for investigating the permeability of CNS therapeutics
S Bergmann, SE Lawler, Y Qu, CM Fadzen, JM Wolfe, MS Regan, ...
Nature protocols 13 (12), 2827-2843, 2018
2102018
Rapid MALDI mass spectrometry imaging for surgical pathology
SS Basu, MS Regan, EC Randall, WM Abdelmoula, AR Clark, ...
NPJ precision oncology 3 (1), 17, 2019
742019
Integrated mapping of pharmacokinetics and pharmacodynamics in a patient-derived xenograft model of glioblastoma
EC Randall, KB Emdal, JK Laramy, M Kim, A Roos, D Calligaris, ...
Nature communications 9 (1), 4904, 2018
742018
Localized metabolomic gradients in patient-derived xenograft models of glioblastoma
EC Randall, BGC Lopez, S Peng, MS Regan, WM Abdelmoula, SS Basu, ...
Cancer research 80 (6), 1258-1267, 2020
682020
Rapid discrimination of pediatric brain tumors by mass spectrometry imaging
AR Clark, D Calligaris, MS Regan, D Pomeranz Krummel, JN Agar, ...
Journal of Neuro-oncology 140, 269-279, 2018
582018
Automatic 3D nonlinear registration of mass spectrometry imaging and magnetic resonance imaging data
WM Abdelmoula, MS Regan, BGC Lopez, EC Randall, S Lawler, ...
Analytical chemistry 91 (9), 6206-6216, 2019
552019
De novo pyrimidine synthesis is a targetable vulnerability in IDH mutant glioma
DD Shi, MR Savani, MM Levitt, AC Wang, JE Endress, CE Bird, J Buehler, ...
Cancer cell 40 (9), 939-956. e16, 2022
492022
Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastoma
BM Marin, KA Porath, S Jain, M Kim, JE Conage-Pough, JH Oh, CL Miller, ...
Neuro-oncology 23 (12), 2042-2053, 2021
402021
A druggable addiction to de novo pyrimidine biosynthesis in diffuse midline glioma
S Pal, JP Kaplan, H Nguyen, SA Stopka, MR Savani, MS Regan, ...
Cancer Cell 40 (9), 957-972. e10, 2022
322022
Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways
S Venneti, AR Kawakibi, S Ji, SM Waszak, SR Sweha, M Mota, M Pun, ...
Cancer discovery 13 (11), 2370-2393, 2023
282023
Single cell spatial analysis reveals the topology of immunomodulatory purinergic signaling in glioblastoma
S Coy, S Wang, SA Stopka, JR Lin, C Yapp, CC Ritch, L Salhi, GJ Baker, ...
Nature communications 13 (1), 4814, 2022
272022
BAF complex maintains glioma stem cells in pediatric H3K27M glioma
E Panditharatna, JG Marques, T Wang, MC Trissal, I Liu, L Jiang, A Beck, ...
Cancer discovery 12 (12), 2880-2905, 2022
252022
Chronic convection-enhanced delivery of topotecan for patients with recurrent glioblastoma: a first-in-patient, single-centre, single-arm, phase 1b trial
EF Spinazzi, MG Argenziano, PS Upadhyayula, MA Banu, JA Neira, ...
The Lancet Oncology 23 (11), 1409-1418, 2022
252022
A unique subset of glycolytic tumour-propagating cells drives squamous cell carcinoma
JE Choi, C Sebastian, CM Ferrer, CA Lewis, M Sade-Feldman, T LaSalle, ...
Nature metabolism 3 (2), 182-195, 2021
232021
In vitro liquid extraction surface analysis mass spectrometry (ivLESA-MS) for direct metabolic analysis of adherent cells in culture
SS Basu, EC Randall, MS Regan, BGC Lopez, AR Clark, ND Schmitt, ...
Analytical chemistry 90 (8), 4987-4991, 2018
232018
β-cyclodextrin-poly (β-amino ester) nanoparticles are a generalizable strategy for high loading and sustained release of HDAC inhibitors
S Chaudhuri, MJ Fowler, C Baker, SA Stopka, MS Regan, L Sablatura, ...
ACS applied materials & interfaces 13 (18), 20960-20973, 2021
182021
Metal oxide laser ionization mass spectrometry imaging (MOLI MSI) using cerium (IV) oxide
SS Basu, MH McMinn, B Giménez-Cassina Lopéz, MS Regan, ...
Analytical chemistry 91 (10), 6800-6807, 2019
172019
PARP-inhibition reprograms macrophages toward an anti-tumor phenotype
L Wang, D Wang, O Sonzogni, S Ke, Q Wang, A Thavamani, F Batalini, ...
Cell reports 41 (2), 2022
162022
massNet: integrated processing and classification of spatially resolved mass spectrometry data using deep learning for rapid tumor delineation
WM Abdelmoula, SA Stopka, EC Randall, M Regan, JN Agar, JN Sarkaria, ...
Bioinformatics 38 (7), 2015-2021, 2022
142022
Interim clinical trial analysis of intraoperative mass spectrometry for breast cancer surgery
SS Basu, SA Stopka, WM Abdelmoula, EC Randall, ...
NPJ Breast Cancer 7 (1), 116, 2021
142021
The system can't perform the operation now. Try again later.
Articles 1–20